Key result
A 63-year-old woman with primary cardiac lymphoma treated with chemoimmunotherapy and prophylactic AICD survived for 7 years before relapsing, suggesting preemptive AICD may prevent early death.
Population
1 63-year-old woman with primary cardiac lymphoma (PCL)
Design
Case_report
Follow-up
7 years
Authors
Loading...
May support prophylactic AICD consideration in primary cardiac lymphoma to avert early arrhythmic death; leaves open need for prospective validation.
Case Report (n=1)
Preemptive implantation of an AICD and chemoimmunotherapy may improve survival in primary cardiac lymphoma by preventing early arrhythmic death.
Singh et al. (2016) conducted a case report in Primary cardiac lymphoma (n=1). Chemoimmunotherapy and prophylactic AICD was evaluated on Survival and relapse. A 63-year-old woman with primary cardiac lymphoma treated with chemoimmunotherapy and prophylactic AICD survived for 7 years before relapsing, suggesting preemptive AICD may prevent early death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: